Outlook Therapeutics, Inc. (OTLK)
NASDAQ: OTLK · Real-Time Price · USD
0.2621
-0.0229 (-8.04%)
At close: Apr 28, 2026, 4:00 PM EDT
0.2654
+0.0033 (1.26%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Outlook Therapeutics Market Cap
Outlook Therapeutics has a market cap or net worth of $27.42 million as of April 28, 2026. Its market cap has decreased by -32.21% in one year.
Market Cap
27.42M
Enterprise Value
57.94M
1-Year Change
-32.21%
Ranking
Category
Stock Price
$0.26
Market Cap Chart
Since June 14, 2016, Outlook Therapeutics's market cap has decreased from $97.37M to $27.42M, a decrease of -71.84%. That is a compound annual growth rate of -12.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 29.82M | -70.57% |
| Dec 31, 2025 | 101.30M | 115.21% |
| Dec 31, 2024 | 47.07M | -54.10% |
| Dec 29, 2023 | 102.54M | -63.01% |
| Dec 30, 2022 | 277.20M | -9.11% |
| Dec 31, 2021 | 304.99M | 84.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tvardi Therapeutics | 29.85M |
| Dyadic International | 29.61M |
| Senti Biosciences Holdings | 29.59M |
| Celularity | 29.42M |
| BriaCell Therapeutics | 29.18M |
| Lisata Therapeutics | 28.72M |
| Kyntra Bio | 28.57M |
| Tevogen Bio Holdings | 28.15M |